Tonsil Hypertrophy Grading
Tonsil hypertrophy is graded 0–4 by the Friedman/Brodsky classification; surgical indication is determined by Paradise criteria for recurrent infection or the presence of sleep apnoea with AHI ≥1.
From a general ENT perspective, Tonsil Hypertrophy Grading connects the patient's description with objective findings. Tonsil hypertrophy is graded 0–4 by the Friedman/Brodsky classification; surgical indication is determined by Paradise criteria for recurrent infection or the presence of sleep apnoea with AHI ≥1. Daily impact, safety signals and response to earlier care must be considered before the term becomes clinically useful. the finding assessment brings nasal-sinus symptoms, this entry throat-tonsil context, the clinical point upper-airway impact and the dictionary entry sleep links into one ENT frame. This dictionary entry is patient education that keeps final decisions tied to examination and current reports. The first clinical frame for this topic is to separate functional impact from safety concerns: Friedman grading: Grade 0 — surgically absent; Grade 1 — hidden in tonsillar fossa behind anterior pillar; Grade 2 — visible beyond pillars, <25% airway; Grade 3 — occupies >25% of airway; Grade 4 — 'kissing tonsils' meeting midline. This distinction prevents rushed treatment decisions.
Evaluation of this term is less about naming the complaint and more about separating risk from functional effect. the finding infection clues, this entry trauma history, allergy-reflux pattern, smoking exposure, occupational load and previous surgery can change the pathway. this term review may combine ENT examination, the finding endoscopic assessment, this entry oral cavity-oropharynx inspection and the clinical point audiological testing when useful. the dictionary entry decisions record fever, this topic pain-bleeding pattern, this term hearing or nasal blockage, the finding sleep impact and this entry infection recurrence separately. Assessment of the clinical point looks for consistency between history and examination: Polysomnography (PSG): per AAO-HNS 2011 PSG guidelines, AHI ≥1/hour is abnormal in children with suspected OSA. If findings do not match, staged reassessment or a second opinion may be clearer than moving directly to a procedure. Tests are meaningful only when they add real value to the clinical plan.
Planning for the finding compares expected benefit, procedural burden and follow-up needs in the same frame. If patient goals and objective findings do not match, the this entry decision is revisited. the clinical point planning discusses medical treatment, the dictionary entry allergy control, this topic endoscopic procedures, this term adenoid-tonsil strategy or the finding airway surgery by indication. The goal in this entry is not to choose the most aggressive option, but to find the right step between safe observation and effective intervention. The selected pathway should fit safe monitoring and realistic outcome expectations.
the clinical point follow-up rereads the original goal, current complaint and examination finding in one file. the dictionary entry follow-up compares pain, this entry nasal openness, the clinical point sleep quality, the dictionary entry hearing impact and this topic infection recurrence over time. When this term is explained, patient goals, medical necessity and realistic expectations meet on the same ground. Review timing changes when the the finding risk profile falls or rises.
Preparation for this entry records the most disturbing symptom, pace of change, daily-life effect and prior treatments separately; these notes make diagnostic questions easier to see; For terminology clarity, tonsil review, hypertrophy report language clarify the patient question.
Diagnosis
Oropharyngeal examination is performed under adequate light. Flexible nasopharyngoscopy is needed for adenoid grading. Polysomnography is indicated when OSA is suspected (AHI ≥1 abnormal in children — AAO-HNS 2011). Modified Epworth Sleepiness Scale or OSA-18 questionnaire is used in paediatric assessment. DISE contributes to surgical planning in selected patients with tongue base tonsillar hypertrophy.
Treatment
Recurrent infection: tonsillectomy (± adenoidectomy) when Paradise criteria are met. OSA: T&A (not tonsillectomy alone) is preferred; intracapsular tonsillectomy is recommended for OSA indication in children due to lower pain and haemorrhage. Adenoidectomy is performed by curettage or microdebrider. Same-day discharge for low-risk children ≥3 years is feasible.
Outcomes and Follow-up
Tonsillectomy reduces pharyngitis from an average of 6.8 to 1.9 episodes per year (AAO-HNS CPG 2019). Paediatric OSA AHI improves 60–70% post-T&A; however residual OSA remains in 20–30% — repeat PSG at 6–8 weeks is recommended. Quality of life improves in 80% at 1 year. Primary haemorrhage <1%, secondary haemorrhage 2–4% (days 5–10).
When to Seek Care
ENT consultation is indicated for Grade 3–4 tonsils with snoring plus witnessed apnoeas or nocturnal gasping, dysphagia, failure to thrive, recurrent peritonsillar abscess, or recurrent throat infections approaching Paradise criteria. In adults with STOP-BANG ≥3 or ESS ≥10, a sleep study should be prioritised.
Frequently asked questions
What is Tonsil Hypertrophy Grading?
When is Tonsil Hypertrophy Grading clinically important?
When is ENT assessment relevant for Tonsil Hypertrophy Grading?
What information helps assessment of Tonsil Hypertrophy Grading?
Learn more about this procedure
Detailed guide from Prof. Dr. Özdoğan's clinic
Related terms
References
This glossary entry is for informational purposes only and does not constitute medical advice. Consult a qualified specialist for diagnosis and treatment.